Driver tests positive for cocaine after fatal cyclist collision
Driver under cocaine influence killed cyclist; victim's husband attacked driver with knife.
Event / Security
Cyclist Death Salornay-sur-Guye
A 33-year-old cyclist was killed on September 24, 2026, in Salornay-sur-Guye, France, after being struck by a speeding driver who tested positive for cocaine. The victim's husband attacked the driver with a cutting tool, causing serious injuries. Two investigations were opened: one for vehicular homicide and one for assault with a weapon.
2 reported locations
Daily activity
1 articles0 articles
2026-09-26 to 2026-11-02 · UTC publication dates
Coverage begins 26 Sept, 11:35 UTC
Follow the documented timeline or explore the related reporting.
What happened
Two separate investigations opened by Mâcon prosecutor
The prosecutor's office in Mâcon opened two distinct investigations: one for vehicular homicide related to the cyclist's death, and a second for assault with a weapon related to the husband's attack on the driver with a cutting tool.
Driver tested positive for cocaine
Blood test results revealed the driver was positive for cocaine at the time of the accident. The test was conducted as part of the investigation into the fatal collision.
33-year-old cyclist killed by speeding driver in Saône-et-Loire
A 33-year-old woman died after being struck by a vehicle while test-riding her new bicycle on a road in front of her home in Salornay-sur-Guye, Saône-et-Loire. She was riding with her two children, aged 8 and 10. The driver was traveling at excessive speed and struck her with violent force, projecting her body and severing one of her arms. She died at the scene.
Victim's husband attacked driver with knife, inflicting serious wounds
After witnessing the accident, the victim's husband confronted the driver who had stopped near the accident scene. The husband attacked the driver with a cutting tool (cutter), inflicting multiple wounds that required helicopter transport to Dijon University Hospital for surgical treatment.
Read the coverage
2 alternative perspectives